Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Rani Therapeutics Holdings Inc Cl A (RANI)

Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rani Therapeutics Holdings Inc Cl A 2051 RINGWOOD AVENUE SAN JOSE CA 95131 USA

www.ranitherapeutics.com P: 408-457-3700

Description:

Rani Therapeutics Holdings Inc. is a clinical stage biotherapeutics company. It focused on advancing technologies to enable the development of orally administered biologics. Rani Therapeutics Holdings Inc. is based in SAN JOSE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 358,623
Enterprise Value, $K 382,143
Shares Outstanding, K 50,157
Annual Sales, $ 0 K
Annual Net Income, $ -33,970 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,100 K
EBIT, $ -66,100 K
EBITDA, $ -67,360 K
60-Month Beta 0.33
% of Insider Shareholders 50.02%
% of Institutional Shareholders 30.19%
Float, K 25,068
% Float 49.98%
Short Volume Ratio 0.29

Growth:

1-Year Return 60.51%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 03/20/24
Latest Earnings Date 05/08/24 [--]
Earnings Per Share ttm -1.33
EPS Growth vs. Prev Qtr 25.00%
EPS Growth vs. Prev Year 22.86%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RANI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -79.92%
Return-on-Assets % -44.07%
Profit Margin % 0.00%
Debt/Equity 1.15
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 12.56
Book Value/Share 0.51
Interest Coverage -12.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar